212

REFERENCES

1. Top 10 Incurable Diseases, 4 October 2007,

http://listverse.com/2007/10/04/top-10-incurable-disea

ses/

2. Treatable diseases, http://www.cryobanksindia.com/

treatable-diseases.html

3. Professor Nicholas White, OBE, University of Oxford,

Plagues and Parasites, http:// royalsociety. org/ Event.

aspx?id=2084& gclid=CO3shLSm7KgCFQd66wodgk3hCw

4. Milder IE, Klungel OH, Mantel-Teeuwisse AK, Verschuren

WM,Bemelmans WJ., Relation between body mass index,

physical inactivity and use of prescription drugs: the

Doetinchem Cohort Study, Int J Obes (Lond). 2010

Jun;34(6):1060-9. Epub 2010 Feb 2

5. Stress From Prostate Cancer Diagnosis May Be Fatal, Dec 2009,

http://www.drugs.com/news/stress-prostate-cancer-diagnosis-m

ay-fatal-21509.html

6. Buyukozturk F, Benneyan JC, Carrier RL, Impact of

emulsion-based drug delivery systems on intestinal

permeability and drug release kinetics, J Control Release.

2010 Feb 25;142(1):22-30. Epub 2009 Oct 20.

7. Side effects of cancer drugs, http://www. cancerhelp.Org

.uk/about-cancer/treatment/cancer-drugs/ side-effects/

8. Treatments and Side effects,http://www.cancer.org/Treat

ment/ Treatments and Side Effects/index

9. Cancer side effects, http://www.drugs.com/cancer.html

10. Cancer Chemotherapy, http://www.nlm.nih. gov/medline

plus /cancerchemotherapy.html

11. Li, S.; He, P.; Dong, J.; Guo, Z.; Dai, L. DNA-directed self-

assembling of carbon nanotubes. J. Am. Chem. Soc. 2005,

127, 14-15; DOI10.1021/ja0446045; PubMed 156 31425.

213

12. Campbell CN, Gal D, Cristler N, Banditrat C, Heller

A.Enzyme-amplified amperometric sandwich test for RNA

and DNA. Anal Chem 2002;74:158_162.

13. Wilson, G.S.; Gifford, R. Biosensors for real-time in vivo

measurements. Biosens. Bioelectron. 2005, 20, 2388-

2403;DOI10.1016/j.bios.2004.12.003;PubMed 15854814.

14. A. C. R. Grayson, I. S. Choi, B. M. Tyler, P. P. Wang, H.

Brem, M. J. Cima, and R. Langer, "Multi-pulse drug

delivery from a resorbable polymeric microchip device,"

Nature Materials, vol. 2, pp. 767-772, 2003.

15. Yogeswaran, U.; Thiagarajan, S.; Chen, S.M.

Nanocomposite of functionalized multiwall carbon

nanotubes with nafion, nano platinum, and nano gold

biosensing film for simultaneous determination of

ascorbic acid, epinephrine, and uric acid. Anal. Biochem.

2007, 365, 122-131; DOI 10.1016/j.ab.2007.02.034;

PubMed 17428433.

16. Balasubramanian, K.; Burghard, M. Biosensors based on

carbon nanotubes. Anal. Bioanal. Chem. 2006, 385, 452-

468;DOI 10.1007/s00216-006-0314-8;PubMed 16568294

17. Zhang, S.; Wang, N.; Niu, Y.; Sun, C. Immobilization of

glucose oxidase on gold nanoparticles modified Au

electrode for the construction of biosensor. Sens. Act. B.

2005, 109, 367-374; DOI 10.1016/j.snb.2004.12.066.

18. Wang, J.; Musameh, M.; Lin, Y. Solubilization of carbon

nanotubes by nafion toward the preparation of

amperometric biosensors. J. Am. Chem. Soc. 2003, 125,

2408-2409; DOI 10.1021/ja028951v; PubMed 12603125.

19. Sun, Y.; Khang, D.Y.; Hua, F.; Hurley, K.; Nuzzo, R.G.;

Rogers, J.A. Photolithographic route to the fabrication of

micro/nanowires of III-V semiconductors. Adv. Funct.

Mater. 2005, 15, 30-40; DOI 10.1002/adfm.200400411.

20. Cheng, F.L.; Zhang, M.L.; Wang, H. Fabrication of

214

polypyrrole nanowire and nanotube arrays. Sensors

2005, 5, 245-249.

21. Collings AF, Caruso F. Biosensors: recent advances. Rep

Prog Phys1997;60: 1397-1445.

22. Jianrong C, Yuqing M, Nongyue H, Xiaohua W, Sijiao L.

Nanotechnology and biosensors. Biotechnol Adv 2004;22:

505-518.

23. 7. Whitesides GM, Ostuni E, Takayama S, Jiang XY,

Ingber DE. Soft lithography in biology and biochemistry.

Annu Rev Biomed Eng 2001;3:335-373.

24. Kubik T, Bogunia-Kubik K, Sugisaka M. Nanotechnology

on duty in medical applications. Curr Pharm Biotechnol

2005;6:17_33.

25. Monk DJ, Walt DR.Optical fiber-based biosensors. Anal

Bioanal Chem 2004;379:931_945.

26. Vo-Dinh T, Cullum B. Biosensors and biochips: advances

in biological and medical diagnostics. Fresenius J Anal

Chem 2000;366:540_551.

27. Suh KY, Khademhosseini A, Yoo PJ, Langer R.Fabrication

of single or aggregated bacteria arrays using host_parasite

and virus_antibody interactions. Biomed Microdevices

2004;6:223_229.

28. Ramanathan K, Danielsson B. Principles and applications

of thermal biosensors. Biosens Bioelectron 2001;16:417_

423.

29. Newman JD, Warner PJ, Turner APF, Tigwell LJ.

Biosensors: A Clearer View. UK: Cranfield University;

2004;p216.

30. Cheng MM, et al. Nanotechnologies for biomolecular

detection and medical diagnostics. Curr Opin Chem Biol

2006;10:11_19.

31. Ziegler C. Cantilever-based biosensors. Anal Bioanal

Chem 2004;379:946_959.

215

32. Gray SA, et al. Design and demonstration of an

automated cell-based biosensor. Biosens Bioelectron

2001;16:535_542.

33. Bolinder J, Ungerstedt U, Arner P.Microdialysis

measurement of the absolute glucose concentration in

subcutaneous adipose tissue allowing glucose monitoring

in diabetic patients. Diabetologia 1992;35:1177_1180.

34. Wang J.Electrochemical nucleic acid biosensors. Anal

Chim Acta 2002;469:63_71.

35. Taitt CR, et al. A portable array biosensor for detecting

multiple analytes in complex samples. Microb Ecol

2004;47:175-185.

36. Ligler FS, et al. Array biosensor for detection of toxins.

Anal Bioanal Chem 2003;377:469_477.

37. Whitesides GM.The right’ size in nanobiotechnology. Nat

Biotechnol 2003;21:1161_1165.

38. Wolfbeis OS. Fiber-optic chemical sensors and biosensors.

Anal Chem 2000;72: 81R_89R.

39. Derfus AM, Chan WCW, Bhatia SN. Intracellular delivery

of quantum dots for live cell labeling and organelle

tracking. Adv Mater 2004;16:961_966.

40. Turner AP, Chen B, Piletsky SA. In vitro diagnostics in

diabetes: meeting the challenge. Clin Chem 999;45:15

96_1601.

41. Wilson GS, Hu Y. Enzyme-based biosensors for in vivo

measurements. Chem Rev 2000;100:2693_2704.

42. J. M. Maloney, S. A. Uhland, B. F. Polito, N. F. Sheppard,

C. M. Pelta, and J. T. Santini, "Electrothermally activated

microchips for implantable drug delivery and biosensing,"

Journal of Controlled Release, vol. 109, pp. 244-255,

2005.

43. E. G. Moran and L. Mont, "Incidence of syncope after ICD

implantation: low or high?," European Heart Journal, vol.

216

27, pp. 2481-2482, 2006.

44. N. T. Nguyen, X. Y. Huang, and T. K. Chuan, "MEMS-

micropumps: A review," Journal of Fluids Engineering-

Transactions of the Asme, vol. 124, pp. 384-392, 2002.

45. J. H. Prescott, S. Lipka, S. Baldwin, N. F. Sheppard, J. M.

Maloney, J. Coppeta, B. Yomtov, M. A. Staples, and J. T.

Santini, "Chronic, programmed polypeptide delivery from

an implanted, multireservoir microchip device," Nature

Biotechnology, vol. 24, pp. 437-438, 2006.

46. G. Kotzar, M. Freas, P. Abel, A. Fleischman, S. Roy, C.

Zorman, J. M. Moran, and J. Melzak, "Evaluation of

MEMS materials of construction for implantable medical

devices," Biomaterials, vol. 23, pp. 2737-2750, 2002

47. Cost of cancer could rise to £25bn in next decade says

think-tank, February 17, 2010, http://www.timesonline

.co.uk/ tol/life_and_style/health/article7029716.ece

48. Robinson, Simon (2008-05-01). "India's Medical

Emergency". Time. http://www.time. com/time/ nation/

article/0,8599,1736, 516,00. html. Retrieved 2010-05-04.

49. http://www.worldbank.org.in/WBSITE/EXTERNAL/COU

NTRIES/SOUTHASIAEXT/INDIAEXTN/0,,contentMDK:21

461167~pagePK:141137~piPK:141127~theSitePK:295584,

00.html

50. http://web.worldbank.org/WBSITE/EXTERNAL/COUNTR

IES/SOUTHASIAEXT/0,,contentMDK:20916955~pagePK:

146736~piPK:146830~theSitePK:223547,00.html.

51. http://www.indianhealthcare.in/index.php?option=com_c

ontent&view=article&catid=39%3A&id=327%3AINDIA+TU

RNING+AFFORDABLE,+QUALITY+OPTION+FOR+MEDICA

L+TOURISTS&Itemid

52. http://www.indianhealthcare.in/index.php?option=com_c

ontent&view=article&catid=122&id=173

217

53. "Healthcare in India". Boston Analytics. http://bostonan

alytics.com/india_watch/Healthcare%20in%20India%20E

xecutive%20Summary.pdf.

54. "Development Policy Review".World Bank. http://web.wor

ldbank.org/WBSITE/EXTERNAL/COUNTRIES/SOUTHAS

IAEXT/0,,contentMDK:20980493~pagePK:146736~piPK:1

46830~theSitePK:223547,00.html.

55. Catalona, W. Clinical utility of measurements of free and

total prostate-specific antigen (PSA): a review. Prostate

1996, 7, 64-69.

56. Beckett, M.; Cazares, L.; Vlahou, A.; Schellhammer, P.;

Wright, G. Prostate-specific membrane antigen levels in

sera from healthy men and patients with benign prostate

hyperplasia or prostate cancer. Clin. Cancer Res. 1995, 5,

4034-4040.

57. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller

GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN,

Lippman SM, Carlin SM, Ryan A, Szczepanek CM,

Crowley JJ, Coltman CA (July 2003). "The influence of

finasteride on the development of prostate cancer". N.

Engl. J. Med. 349 (3): 215–24. doi:10.1056/NEJMoa0306

60. PMID 12824459.

58. Andriole GL, Roehrborn C, Schulman C, Slawin KM,

Somerville M, Rittmaster RS (September 2004). "Effect of

dutasteride on the detection of prostate cancer in men

with benign prostatic hyperplasia". Urology 64 (3): 537–

41; discussion 542–3. doi:10.1016/j.urology.2004.04.084.

PMID 15351586.

59. Dimitropoulou P, Lophatananon A, Easton D, Pocock R,

Dearnaley DP, Guy M, Edwards S, O'Brien L, Hall A,

Wilkinson R, Eeles R, Muir KR (January 2009). "Sexual

activity and prostate cancer risk in men diagnosed at a

218

younger age". BJU Int. 103 (2): 178–85.

doi:10.1111/j.1464-410X.2008.08030.x. PMID 19016689.

60. Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM,

Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ,

D'Agostino R, Zhang H, Wu H, Kang JX, Chen YQ (July

2007). "Modulation of prostate cancer genetic risk by

omega-3 and omega-6 fatty acids". J. Clin. Invest. 117 (7):

1866–75. doi:10.1172/JCI31494.PMC 1890998.PMID 17

607361. http: //www.pubmedcentral .nih.gov/ artic

lerender.fcgi?tool=pmcentrez&artid=1890998.

61. Mongiat-Artus P, Peyromaure M, Richaud P, Droz JP,

Rainfray M, Jeandel C, Rebillard X, Moreau JL, Davin JL,

Salomon L, Soulié M (December 2009)."[Recomm

endations for the treatment of prostate cancer in the

elderly man: A study by the oncology committee of the

French association of urology]" (in French). Prog. Urol. 19

(11):810–7. doi: 10.1016 /j.purol. 2009.02.008.

PMID 19945664.

62. Picard JC, Golshayan AR, Marshall DT, Opfermann KJ,

Keane TE (November 2009). "The multi-disciplinary

management of high-risk prostate cancer". Urol. Oncol..

doi:10.1016 /j.urolonc.2009.09.002. PMID 19945310.

63. How much the cost of doctor for a visit, http :// able

2know .org/topic/94868-1

64. www.prb.org/presentations/g_avail-doctors.ppt

65. Joseph I. Boullata PharmD, RPh, BCNSP Drug Admin

istration Through an Enteral Feeding Tube AJN, American

Journal of Nursing, October 2009, Volume 109 Number

10, Pages 34 - 42

66. van den Bemt PM, et al. Quality improvement of oral

medication administration in patients with enteral feeding

tubes. Qual Saf Health Care 2006;15(1):44-7.

67. J. M. Maloney, S. A. Uhland, B. F. Polito, N. F. Sheppard,

219

C. M. Pelta, and J. T. Santini, "Electrothermally activated

microchips for implantable drug delivery and biosensing,"

Journal of Controlled Release, vol. 109, pp. 244-255,

2005.

68. RFID based drug delivery unit, works.bepress.com/cgi/

69. J. T. Santini, M. J. Cima, and R. Langer, "A controlled-

release microchip," Nature, vol. 397, pp.335-338, 1999.

70. J . T. Santini, A. C. Richards, R. Scheidt, M. J. Cima, and

R. Langer, "Microchips as controlled drug-delivery

devices," Angewandte Chemie-International Edition, vol.

39, pp. 2397-2407, 2000.

71. M. Staples, K. Daniel, M. J. Cima, and R. Langer,

"Application of micro- and nano-electromechanical devices

to drug delivery," Pharmaceutical Research, vol. 23, pp.

847- 863, 2006

72. G. Voskerician, M. S. Shivea, R. S. Shawgo, H. v. Recum,

J. M. Anderson, M. J. Cima, and R. Langer,

"Biocompatibility and Biofouling of MEMS Drug Delivery

Devices," Biomaterials, vol. 24, pp. 1959 - 1967, 2003

73. J. T. Santini, M. J. Cima, and R. Langer, "A controlled

release microchip," Nature, vol. 397, pp.335-338, 1999.

74. Muller, R; Keck, C (2004). "Challenges and solutions for

the delivery of biotech drugs – a review of drug

nanocrystal technology and lipid nanoparticles". Journal

of Biotechnology 113 (1–3): 151–170.doi:10.1016/j.jbio

tec.2004.06.007. PMID 15380654.

75. Singh, Monica; Singh, Puneetpal; Juneja, Pawan Kumar;

Singh, Surinder; Kaur, Taranpal (2010). "SNP–SNP

interactions within APOE gene influence plasma lipids in

postmenopausal osteoporosis". Rheumatology Internatio

nal 31 (3): 421–3. doi: 10.1007/s00296-010-1449-7.

PMID 20340021.

76. Morita, Akihiko; Nakayama, Tomohiro; Doba, Nobutaka;

220

Hinohara, Shigeaki; Mizutani, Tomohiko; Soma,

Masayoshi (2007). "Genotyping of triallelic SNPs using

TaqMan® PCR". Molecular and Cellular Probes 21 (3):

171–6. doi: 10.1016/j.mcp.2006.10.005. PMID 17161935.

77. FDA registration for drug delivery, www .registrar corp.

com / Register-FDA

78. Frank Davis and Séamus P . J . Higson, Trends in

Biosensing, http:// www.crcnetbase. com/doi/abs/10.12

01/b10466-13

79. Tuan Vo-Dinh · Brian Cullum, Biosensors and biochips:

advances in biological and medical diagnostics, Fresenius

J Anal Chem (2000) 366 :540–551

80. Valcke, Christian and Chizeck, Howard Jay. Closed-Loop

Drug Infusion for Control of Heart-Rate trajectory in

Pharmacological Stress Tests, IEEE Transactions on

Biomedical Engineering, 44(3), 187-195 (1997).

81. Woodruff, Eileen A.; Martin, James F.; and Omens,

Madonna. A Model for the Design and Evaluation of

Algorithms for Closed-Loop Cardiovascular Therapy, IEEE

Transactions on Biomedical Engineering, 44(8), 694-705

(1997).

82. Yu, Clement; Roy, Rob J.; Kaufman, Howard; and

Bequette, B. Wayne. Multiple-Model Adaptive Predictive

Control for Mean Arterial Pressure and Cardiac Output,

IEEE Transactions on Biomedical Engineering, 39(8), 765-

778 (1992)

83. J. H. Prescott, S. Lipka, S. Baldwin, N. F. Sheppard, J. M.

Maloney, J. Coppeta, B. Yomtov, M. A. Staples, and J. T.

Santini, "Chronic, programmed polypeptide delivery from

an implanted, multireservoir microchip device," Nature

Bio tech nology, vol. 24, pp. 437-438, 2006.

221

84. N. T. Nguyen, X. Y. Huang, and T. K. Chuan, "MEMS-

micropumps: A review," Journal of Fluids Engineering-

Transactions of the Asme, vol. 124, pp. 384-392, 2002.

85. J . T. Santini, A. C. Richards, R. Scheidt, M. J. Cima, and

R. Langer, "Microchips as controlled drug-delivery

devices," Angewandte Chemie-International Edition, vol.

39, pp. 2397-2407, 2000.

86. A. C. R. Grayson, I. S. Choi, B. M. Tyler, P. P. Wang, H.

Brem, M. J. Cima, and R. Langer, "Multi-pulse drug

delivery from a resorbable polymeric microchip device,"

Nature Materials, vol. 2, pp. 767-772, 2003.

87. J. M. Maloney, S. A. Uhland, B. F. Polito, N. F. Sheppard,

C. M. Pelta, and J. T. Santini, "Electrothermally activated

microchips for implantable drug delivery and biosensing,"

Journal of Controlled Release, vol. 109, pp. 244-255,

2005.

88. A. C. R. Grayson, M. J. Cima, and R. Langer, "Size and

temperature effects on poly(lactic-co-glycolic acid)

degradation and microreservoir device performance,"

Biomaterials, vol. 26, pp. 2137-2145, 2005.

89. T. Vo-Dinh, Editor, Nanotechnology in Biology and

Medicine (2007)

90. R. Bashir, R. Gomez, M. Ladisch, A. Bhunia, J. P.

Robinson, US Patent # 6,716, 620, April 6th, 2004,

"Biosensor and Related Method".

91. Fagerstam LG, et al. Detection of antigen-antibody

interactions by surface Plasmon resonance. Application to

epitope mapping. J Mol Recognit 1990;3:208-214

92. Wilson GS, Hu Y. Enzyme-based biosensors for in vivo

measurements. Chem Rev 2000;100:2693_2704.

93. Seeman (2005) From genes to machines: DNA

nanomechanical devices. TRENDS in Biochemical

Sciences

222

94. Guan and Lee (2005) Generating highly ordered DNA

nanostrand arrays. PNAS 102(51) pp. 18321-25

95. Fehm T, et al. Cytogenetic evidence that circulating

epithelial cells in patients with carcinoma are malignant.

Clin Cancer Res 2002;8:2073_2084.

96. Cristofanilli M, et al. Circulating tumor cells, disease

progression, and survival in metastatic breast cancer. N

Engl J Med 2004;351:781_791.

97. (a) Chen, R. J.; Bangsaruntip, S.; Drouvalakis, K. A.; Shi

Kam, N. W.; Shim, M.; Li, Y.; Kim, W.; Utz, P. J.; Dai, H.

Proc. Natl. Acad. Sci.U.S.A. 2003, 100, 4984. (b) Star, A.;

Gabriel, J. P.; Bradley, K.; Gruner,G. Nano Lett. 2003, 3,

459. (c) Chen, R. J.; Zhang, Y.; Wang, D.; Dai,H. J. Am.

Chem. Soc. 2001, 123, 3838. (d) Nguyen, C. V.; Delzeit,

L.;Cassell, A. M.; Li, J.; Han, J.; Meyyappan, M. Nano

Lett. 2002, 2, 1079.(e) Koehne, J. E.; Chen, H.; Cassell, A.

M.; Ye, Q.; Han, J.; Meyyappan, M.; Li, J. Clin. Chem.

2004, 50, 1886.

98. Wang J., Liu G.D., Wu H., and Lin Y.H. Sensitive

electrochemical immunoassay for 2, 4, 6-trinitrotoluene

based on functionalized silica nanoparticle labels. Anal

Chim Acta 2008c: 610(1): 112–118.

99. J. M. Maloney, S. A. Uhland, B. F. Polito, N. F. Sheppard,

C. M. Pelta, and J. T. Santini, "Electrothermally activated

microchips for implantable drug delivery and biosensing,"

Journal of Controlled Release, vol. 109, pp. 244-255,

2005.

100. C. N. Rao, B. C. Satishkumar, A. Govindaraj, M. Nath,

Chem PhysChem. 2001, 79.

101. J. J. Davis, K. Coleman, B. Azamian, C. Bagshaw, M. L.

Green, Chem. Eur. J. 2003, 9, 3732.

102. R. H. Baughman, A. Zakhidov, W. A. de Heer, Science

2002, 297, 787.

223

103. Q. Zhao, Z. Gan, Q. Zhuang, Electroanalysis 2002, 14,

1609.

104. Connor, E.; Mwamuka, J.; Gole, A.; Murphy, C.; Wyatt,

M.Gold nanoparticles are taken up by human cells but

do not cause acute cytotoxicity. Small 2005, 1, 325-327.

105. Medly, C.; Smith, J.; Tang, Z.; Wu, Y.; Bamrungsap, W.;

Tan, W. Gold nanoparticle-based colorimetric assay for

the direct detection of cancerous cells. Anal. Chem. 2008,

80, 1067- 1072.

106. Copland, J.; Eghtedari, M.; Popov, V.; Kotov, N.;

Mamedova, N.; Motamedi, M.; Oraevsky, A. Bioconju

gated gold Nano particles as a molecular based

contrast agent: implications for imaging of deep tumors

using optoacoustic tomography.

Mol.Imaging Biol. 2004, 6, 341-349.

107. Liu, Z.; Searson, P.C. Single nanoporous gold nanowire

Sensors. J. Phys. Chem. B. 2006, 110, 4318-4322; DOI

10.1021/jp056940t; PubMed 16509729.

108. Huang, X.; Qian, W.; El-Sayed, I.; El-Sayed, M. The

potential use of the enhanced nonlinear properties of

gold nanospheres in photothermal cancer therapy.

Laser. Surg. Med. 2007, 39, 747-753.

109. M. Staples, K. Daniel, M. J. Cima, and R. Langer,

"Application of micro- and nano-electromechanical

devices to drugdelivery” Pharmaceutical Research, vol.

23, pp. 847- 863, 2006.

110. Henderson, C.; Patek, A. The relationship between

prognostic and predictive factors in the management of

breast cancer. Breast Cancer Res. Treat. 1998, 52, 261-

288

111. Molina, R.; Auge, J.; Escudero, J.; Marrades, R.; Vinolas,

N.; Carcereny, E.; Ramirez, J.; Filella, X. Mucins CA 125,

CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in

224

patients with lung cancer: comparison with CYFRA 21-1,

CEA, SCC and NSE. Tumor Biol. 2008, 29, 371-380.

112. Ramgir, N.S.; Zajac, A.; Sekhar, P.K.; Lee, L.; Zhukov,

T.A.; Bhansali, S. Voltammetric detection of cancer

biomarkers exemplified by interleukin-10 and

osteopontin with silica nanowires. J. Phys. Chem. C.

2007, 111, 13981-13987; DOI 10.1021/jp073371b.

113. Wang, J.; Liu, G.; Wu, H.; Lin, Y. Quantum-dot-based

electrochemical immunoassay for high-throughput

screening of the prostate-specific antigen. Small 2007, 4,

82-86.

114. Pietryga, J.; Schaller, R.; Werder, D.; Stewart, M.;

Klimov, V.; Hollingsworth, J. Pushing the band gap

envelope: mid-infrared emitting colloidal PbSe quantum

dots. J. Am. Chem. Soc. 2004, 126, 11752-11753.

115. Huang, X.; El-Sayed, I.; Qian, W.; El-Sayed, M. Cancer

cell imaging and photothermal therapy in the near-

infrared region by using gold nanorods. J. Am. Chem.

Soc. 2006, 128, 2115-2120.

116. Wang, J.; Kawde, A.; Musameh, M. Carbon-nanotube-

modified glassy carbon electrodes for amplified label-free

electrochemical detection of DNA hybridization. Analyst

2003, 128, 912-916.

117. Yu, X.; Munge, B.; Patel, V.; Jensen, G.; Bhirde, A.;

Gong, J.; Kim, S.; Gillespie, J.; Gutkind, J.;

Papadimitrakopoulos, F.; Rusling J. Carbon nanotube

amplification strategies for highly sensitive

immunodetection of cancer biomarkers. J. Am. Chem.

Soc. 2006, 128, 11199-11205.

118. Bi, S.; Zhou, H.; Zhang, S. Multilayers enzyme-coated

carbon nanotubes as biolabel for ultrasensitive

chemiluminescence immunoassay of cancer biomarker.

Biosens. Bioelectron. 2009, 24, 2961-2966.

225

119. Ramgir, N.; Zajac, A.; Sekhar, P.; Lee, L.; Zhukov, T.;

Bhansali, S. Voltammetric detection of cancer

biomarkers exemplified by interleukin-10 and

osteopontin with silica nanowires. J. Phys. Chem. C

2007, 111, 13981-13987.

120. Sekhar, P.; Ramgir, N.; Joshi, R.; Bhansali, S. Selective

growth of silica nanowires using an Au catalyst for

optical recognition of interleukin-10. Nanotechnology

2008, 19, 245502-245507.

121. Sekhar, P.; Ramgir, N.; Bhansali, S. Metal-decorated

silica nanowires: an active surface-enhanced Raman

substrate for cancer biomarker detection. J. Phys.

Chem. C 2008, 112, 1728-1734.

122. Patil, S.; Zajac, A.; Zhukov, T.; Bhansali, S.

Ultrasensitive electrochemical detection of cytokeratin-7,

using Au nanowires based biosensor. Sensor Actuator B

Chem. 2008, 129, 859-865.

123. Fang, Z.; Soleymani, L.; Pampalakis, G.; Yoshimoto, M.;

Squire, J.; Sargent, E.; Kelley, S. Direct profiling of

cancer biomarkers in tumor tissue using a multiplexed

nanostructured microelectrode integrated circuit. ACS

NANO 2009, 3, 3207-3213.

124. Bangar, M.; Shirale, D.; Chen, W.; Myung, N.;

Mulchandani, A. Single conducting polymer nanowire

chemiresistive label-free immunosensor for cancer

biomarker. Anal. Chem. 2009, 81, 2168-2175.

125. Wu, G.; Ji, H.; Hansen, K.; Thundat, T.; Datar, R.; Cote,

R.; Hagan, M.; Chakraborty, A.; Majumdar, A. Origin of

nanomechanical cantilever motion generated from

biomolecular interactions. Proc. Natl. Acad. Sci. USA

2001, 98, 1560-1564.

126. Lee, H.; Kim, K.; Kim, C.; Hahn, S.; Jo, M. Electrical

detection of VEGFs for cancer diagnoses using anti-

226

vascular endothelial growth factor aptamer-modified Si

nanowire FETs. Biosens. Bioelectron. 2009, 24, 1801-

1805.

127. Murray, B.J.; Walter, E.C.; Penner, R.M. Amine vapor

sensing with silver mesowires. Nano Lett. 2004, 4, 665-

670; DOI 10.1021/nl049841k

128. Li, C.; Curreli, M.; Lin, H.; Lei, B.; Ishikawa, F.; Datar,

R.; Cote, R.; Thompson, M.; Zhou, C. Complementary

detection of prostate-specific antigen using In2O3

nanowires and carbon nanotubes. J. Am. Chem. Soc.

2005, 127, 12484-12485.

129. Basu, M.; Seggerson, S.; Henshaw, J.; Jiang, J.;

Cordona, R.D.A.; Lefave, C.; Boyle, P.J.; Miller, A.; Pugia,

M.; Basu, S. Nano-biosensor development for bacterial

detection during human kidney infection: Use of

glycoconjugate-specific antibody-bound gold NanoWire

arrays (GNWA). Glycoconjugate Journal. 2004, 21, 487-

496; DOI 10.1007/s10719-004-5539-1; PubMed 157507

90.

130. Melancon, M.; Lu, W.; Yang, Z.; Zhang, R.; Cheng, Z.;

Elliot, A.; Stafford, J.; Olson, T.; Zhang, J.; Li, C. In vitro

and in vivo targeting of hollow gold nanoshells directed at

epidermal growth factor receptor for photothermal

ablation therapy. Mol. Cancer Ther. 2008, 7, 1730-1739.

131. Zhang, J.; Lang, H.; Huber, F.; Bietsch, A.; Grange, W.;

Certa, U.; Mckendry, R.; Güntherodt, H.; Hegner, M.;

Gerber, C. Rapid and label-free nanomechanical

detection of biomarker transcripts in human RNA. Nat.

Nanotechnol. 2006, 1, 214-220.

132. Yue, M.; Stachowiak, J.; Lin, H.; Datar, R.; Cote, R.;

Majumdar, A. Label-free protein recognition two-

dimensional array using nanomechanical sensors. Nano

Lett. 2008, 8, 520-524.

227

133. www.nanohub.org/simulation tools for nanobio sensors

134. Cross, S.; Jin, Y.; Rao, J.; Gimzewski, J. Nanomechanical

analysis of cells from cancer patients. Nat. Nanotechnol.

2007, 2, 780-783.

135. Movileanu, L.; Howorka, S.; Braha, O.; Bayley, H.

Detecting protein analytes that modulate transmembrane

movement of a polymer chain within a single protein pore.

Nat. Biotechnol. 2000, 18, 1091-1095.

136. Drug delivery and nanoparticles: Applications and

hazards, Wim H De Jong1 and Paul JA Borm, Int J

Nanomedicine. 2008 June; 3(2): 133–149.

137. Status of Malaria in India". http:// medind .nic. in/jac /

t00 / i1/jact00i1p19.pdf.

138. Blumberg HM, Leonard MK, Jasmer RM (2005). "Update

on the treatment of tuberculosis and latent tuberculosis

infection". JAMA 293 (22): 2776–84. doi:10.1001/jama.

293.22.2776. PMID 15941808

139. Robinson, Simon (2008-05-01). "India's Medical

Emergency". Time. http:// www.time.com/ time/nation/

article/0,8599,1736516,00.html. Retrieved 2010-05-04.

140. http://www.ibef.org/industry/healthcare.aspx

141. Trowbridge EA, Martin JF, Slater DN. Evidence for a

theory of physical fragmentation of megakaryocytes,

implying that all platelets are produced in the pulmonary

circulation. Thromb Res 1982;28:461-75.

142. Martin JF, Shaw T, Heggie J, Penington DG.

Measurement of the density of human platelets and its

relationship to volume. Br3 Haematol 1983;54 :337-52.

143. Maluenda G, Lemesle G, Collins S et al.: The clinical

significance of hematocrit values before and after

percutaneous coronary intervention. Am. Heart J. 158(6)

1024–1030 (2009).

228

144. Thakur ML, Devadhas D, Zhang K et al.: Imaging

spontaneous MMTVneu transgenic murine mammary

tumors: targeting metabolic activity versus genetic

products. J. Nucl. Med. 51(1), 106–111 (2009).

145. http://www.bloodbook.com/test-result.html

146. "International Classification of Diseases, Tenth Revision,

Clinical Modification (ICD-10-CM)". National Center for

Health Statistics. Centers for Disease Control and

Prevention (CDC). December 20, 2010

147. U.S. Department of Health & Human Services (August 15,

2008). "HHS Proposes Adoption of ICD-10 Code Sets and

Updated Electronic Transaction Standards". Press release.

http://www.dhhs.gov/news/press/2008pres/08/200808

15a.html. Retrieved 2008-10-22.

148. LaFleur-Brooks, M. (2008). Exploring Medical Language:

A Student-Directed Approach, 7th Edition. St. Louis,

Missouri, USA: Mosby Elsevier. pp. 398. ISBN 978-0-323-

04950-4.

149. Maton, D., Hopkins, J., McLaughlin, Ch. W., Johnson, S.,

Warner, M. Q., LaHart, D., & Wright, J. D. (1000008).

Human Biology and Health. Englewood Cliffs, New Jersey,

USA: Prentice Hall. ISBN 0-13-981176-1.

150. Alberts, B. (2005). "Leukocyte functions and percentage

breakdown". Molecular Biology of the Cell. NCBI Bookshe

lf.http://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight=

leukocyte, functions & rid= mboc4.table.4143.Retrieved

20 07-04-14.

151. Gartner, L. P., & Hiatt, J. L. (2007). Color Textbook of

Histology (3rd ed.). Philadelphia, PA: SAUNDERS Elsevier.

pp. 225. ISBN 978-1-4160-2945-8.

152. Krombach, F., Münzing, S., Allmeling, A. M., Gerlach, J.

T., Behr, J., & Dörger, M. (1 September 1997). "Cell size of

alveolar macrophages: an interspecies comparison".

229

Environ. Health Perspect. (Brogan & Partners) 105 Suppl

5: 1261–3. doi:10.2307/3433544. ISSN 00916765.

JSTOR 3433544. PMC 1470168. PMID 9400735.http://

www.Pubmedcentral .nih.gov/articlerender.fcgi?tool=pmc

entrez&artid=1470168

153. Pantaleo, G., Demarest, J. F., Soudeyns, H., et. al.

(August 1994). "Major expansion of CD8+ T cells with a

predominant V beta usage during the primary immune

response to HIV". Nature 370 (6489): 463–7.

doi:10.1038/370463a0. PMID 8047166.

154. Drug dosage calculation, http://www. mapharm. Com /

dosage_calc.htm

155. Drug calculation, www.davesems.com/files/

156. Goessl C, Krause H, Muller M, et al. Fluorescent

methylationspecific polymerase chain reaction for DNA-

based detection of prostate cancer in bodily fluids. Cancer

Res 2000; 60: 5941-5.

157. Djulbegovic M, Beyth RJ, Neuberger MM, et al. (2010).

"Screening for prostate cancer: systematic review and

meta-analysis of randomised controlled trials". BMJ 341:

c4543. doi:10.1136/bmj.c4543. PMC 2939952.PMID20

843937

158. Miller DC, Hafez KS, Stewart A, Montie JE, Wei JT

(September 2003). "Prostate carcinoma presentation,

diagnosis, and staging: an update form the National

Cancer Data Base". Cancer 98 (6): 1169–78.

doi:10.1002/cncr.11635. PMID 12973840

159. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC

(April 2001). "Ovarian surface epithelium: biology,

endocrinology, and pathology". Endocr. Rev. 22 (2): 255–

88. doi:10.1210/ er.. 2.255. PMID 11294827. http://edrv.

endo journals.org/cgi/pmidlookup?view=long&pmid=112

94827.

230

160. Robert C. Young (2005). "Ch. 83, Gynecologic

Malignancies". In Jameson JN, Kasper DL, Harrison TR,

Braunwald E, Fauci AS, Hauser SL, Longo DL. Harrison's

principles of internal medicine (16th ed.). New York:

McGraw-Hill Medical Publishing Division. ISBN 0-07-

140235-7. http://highered.mcgraw-hill. com/sites/0071

402357/information_center_view0/.

161. Gynecologic Neoplasms at Merck Manual of Diagnosis and

Therapy Professional Edition

162. Vockenroth I, Atanasova P, Knoll W, Jenkins A, Köper I

(2005). "Functional tethered bilayer membranes as a

biosensor platform". IEEE Sensors 2005 - The 4-th IEEE

Conference on Sensors: 608–610.

163. Cornell BA, BraachMaksvytis VLB, King LG, et al. (1997).

"A biosensor that uses ion-channel switches". Nature 387

(6633): 580–583.

164. Oh S, Cornell B, Smith D, et al. (2008). "Rapid detection

of influenza A virus in clinical samples using an ion

channel switch biosensor". Biosensors & Bioelectronics 23

(7): 1161–1165.

165. Krishnamurthy V, Monfared S, Cornell B (2010). ": Ion

Channel Biosensors Part I Construction Operation and

Clinical Studies". IEEE Transactions on Nanotechnology 9

(3): 313–322.

166. Pohanka M, Skladal P, Kroca M (2007)."Biosensors for

biological warfare agent detection". Def. Sci. J. 57(3):185-

93.

167. Chau, L.-K.; Lin, Y.-F.; Cheng, S.-F.; Lin, T.-J. “Fiber-

optic chemical and biochemical probes based on localized

surface plasmon resonance.” Sens. Actuators B 2006,

113, 100-105.

168. Chen, C.-D.; Cheng, S.-F.; Chau, L.-K.; Wang, C. R. C.

“Sensing Capability of the Localized Surface Plasmon

231

Resonance of Gold Nanorods.” Biosens. Bioelectron. 2007,

22, 926-932.

169. Peng, G.; Tisch, U.; Haick, H. Detection of nonpolar

molecules by means of carrier scattering in random

networks of carbon nanotubes: toward diagnosis of

diseases via breath samples. Nano Lett. 2009, 9, 1362-

1368.

170. Hahm, J.; Lieber, C. Direct ultrasensitive electrical

detection of DNA and DNA sequence variations using

nanowire nanosensors. Nano Lett. 2004, 4, 51-54.

171. Patolsky, F.; Zheng, G.; Hayden, O.; Lakadamyali, M.;

Zhuang, X.; Lieber, C. Electrical detection of single

viruses. Proc. Natl. Acad. Sci. USA 2004, 101, 14017-

14022.

172. Christopher R. Lowe, Overview of Biosensor and Bioarray

Technologies, Wiley publications

173. Fan, Y.; Chen, X.; Trigg, A.; Tung, C.; Kong, J.; Gao, Z.

Detection of microRNAs using target-guided formation of

conducting polymer nanowires in nanogaps. J. Am.

Chem. Soc. 2007, 129, 5437-5443.

174. Walsh PC, Lepor H, Eggleston JC (1983). "Radical

prostatectomy with preservation of sexual function:

anatomical and pathological considerations". The Prostate

4 (5): 473–85. doi:10.1002/pros.2990040506. PMID 6889

192.

175. Huggins CB, Hodges CV (1941). "Studies on prostate

cancer: 1. The effects of castration, of estrogen and

androgen injection on serum phosphatases in metastatic

carcinoma of the prostate". Cancer Res

176. Schally AV, Kastin AJ, Arimura A (November 1971).

"Hypothalamic follicle-stimulating hormone (FSH) and

luteinizing hormone (LH)-regulating hormone: structure,

physiology, and clinical studies". Fertility and Sterility 22

232

(11): 703–21. PMID 4941683.

177. Tolis G, Ackman D, Stellos A, et al. (March 1982). "Tumor

growth inhibition in patients with prostatic carcinoma

treated with luteinizing hormone-releasing hormone

agonists". Proc. Natl. Acad. Sci. U.S.A 79 (5): 1658–62.

doi:10.1073 /pnas.79.5.1658.PMC 346035.PMID 646186

1. http://www .pub medcentral.nih.gov/art icleerender.f

cgi?tool=pmcentrez&artid=346035.

178. Denmeade SR, Isaacs JT (May 2002). "A history of

prostate cancer treatment". Nature Reviews. Cancer 2 (5):

389–96. doi:10.1038/nrc801. PMID 12044015.

179. Andreescu S., and Marty J.-L. Twenty years research in

cholinesterase biosensors: from basic research to

practical applications. Biomol Eng 2006: 23: 1–15.

180. Authier L., Grossiord C., Brossier P., and Limoges B. Gold

nanoparticle-based quantitative electrochemical detection

of amplified human cytomegalovirusDNA using disposable

microband electrodes. Anal Chem 2001: 73: 4450–4456.

181. Badihi-Mossberg M., Buchner V., and Rishpon J.

Electrochemical biosensors for pollutants in the

environment. Electroanalysis 2007: 19: 2015–2028.

182. Bard A.J., and Faulkner L.R. Electrochemical Methods:

Fundamentals and Applications. John Wiley and Sons

Inc., New York, 1980, pp 413–414.

183. Chen S.H., Yuan R., ChaiY.Q., Zhang L.Y., Wang N., and

Li X.L.Amperometric third-generation hydrogen peroxide

biosensor based on the immobilization of hemoglobin on

multiwall carbon nanotubes and gold colloidal

nanoparticles. Biosens Bioelectron 2007: 22: 1268–1274.

184. Drummond T.G., Hill M.G., and Barton J.K.

Electrochemical DNA sensors. Nat. Biotechnol 2003:21

(10): 1192–1199.

185. Guo S.J., and Wang E.K. Synthesis and electrochemical

233

applications of gold nanoparticles. Anal Chim Acta 2007:

598: 181–192.

186. Hainfeld J.F., and Powell R.D. New frontiers in gold

labeling. J Histochem Cytochem 2000: 48: 471–480.

187. Hala´mek J., Hepel M., and Skladal P. Investigation of

highly sensitive piezoelectric immunosensors for 2,4-

dichloro phenoxy acetic acid.

188. MerkociA., Aldavert M., Tarrason G., Eritja R., and Alegret

S. Toward and ICPMS-linked DNA assay based on gold

nanoparticles immunoconnected through peptide

sequences. Anal Chem 2005: 77: 6500–6503.

189. K.J. Astrom and T.Hagglund. PID Controllers, 2nd ed.,

Instrument Society of America, 1995.

190. Arbib, Michael A. (Ed.) (1995). The Handbook of Brain

Theory and Neural Networks.

191. Alspector, U.S. Patent 4,874,963 "Neuromorphic learning

networks". October 17, 1989.

192. L. Chua and L. Yang, "Cellular Neural Networks: Theory,"

IEEE Trans. on Circuits and Systems, 35(10):1257-1272,

1988.

193. Pearson, K. (1901). "On Lines and Planes of Closest Fit to

Systems of Points in Space" (PDF). Philosophical Magazine

2(6):559–572.http://stat.smmu.edu.cn/history/pearson 1

01.pdf.

194. Jolliffe I.T. Principal Component Analysis, Series: Springer

Series in Statistics, 2nd ed., Springer, NY, 2002, XXIX,

487 p. 28 illus. ISBN 978-0-387-95442-4

195. Ang, K.H., Chong, G.C.Y., and Li, Y. (2005). PID control

system analysis, design, and technology, IEEE Trans

Control Systems Tech, 13(4), pp.559-576. http://eprints.

gla.ac.uk/3817/

196. www.xilinx.com

234

197. Computer Architecture: A quantitative Approach,

Hennessy and Patterson, 1990, Morgan Kafmann

Publishers, Inc. Section A.2 (pages A-3 through A-6) and

section A.9 (pages A-39 through A-49).

198. Shanthala. S, and Dr. S. Y. Kulkarni “VLSI design and

implementation of Low Power MAC unit with Block

Enabling technique” published in the Journal “European

Journal of Scientific Research” Vol. 30, No. 4, (2009) , pp.

620-630, during April 2009.

199. Shanthala. S and Dr. S. Y. Kulkarni “Design of a Low

Power and High Speed Floating Point Arithmetic Unit

using 180nm technology” published in the Journal

‘European Journal of Scientific Research’ Vol. 31, No. 1,

(2009), pp. 19-28, during May 2009